Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?
This article is to examine and summarize the 2 opposing viewpoints and provide guideline recommendations to support the use or discontinuation of ACE inhibitors and ARBs in patients with COVID-19.
Source: Cardiology in Review - Category: Cardiology Tags: Feature Curbside Consult Source Type: research
More News: Cardiology | Coronavirus | COVID-19 | Gastroenterology | Heart | Respiratory Medicine | SARS | Study | Urology & Nephrology | USA Health